Mary Chantal Hillarby

Mary Chantal Hillarby

Auto-generated profile, based on publicly available information

Mary Chantal Hillarby

Division of Pharmacy and Optometry‐ School of Health Sciences University of Manchester Manchester UK

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2008 in Eye
Verified
Journal Article
Closed access
IRI Rahman
I Rahman
FCF Carley
F Carley
CHC Hillarby
C Hillarby
ABA Brahma
A Brahma
ATA B Tullo
A B Tullo

1 January 1995 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
EDEric J. Davies
Eric J. Davies
NSNeil Snowden
Neil Snowden
MHM. Chantal Hillarby
M. Chantal Hillarby
DCDavid Carthy
David Carthy
DGDavid M. Grennan
David M. Grennan
WOWilliam E. R. Ollier
William E. R. Ollier
Objective. To determine whether an allelic form of mannose-binding protein (MBP) incapable of activating complement is associated with susceptibility to systemic lupus erythematosus (SLE). Methods. MBP allele frequencies were determined by amplification refractory mutation system–polymerase chain reaction in 102 white SLE patients and 136 controls. Results. The MBP allele that is unable to activate complement was present in 42 SLE patients (41%) and in 41 controls (30%) (P = 0.08, odds ratio [OR] = 1.6, 95% confidence interval [95% CI] 1.0–2.8). The gene frequency of this allele was 0.25 in SLE patients and 0.19 in controls (P = 0.08, OR = 1.5, 95% CI 1.0–2.3). Conclusion. Our results suggest that this allele of the MBP gene represents a minor risk factor for SLE.

1 April 2012 in Pathology
Verified
Journal Article
Closed access
PDF file
ESE. Sykakis
E. Sykakis
FCF. Carley
F. Carley
LIL. Irion
L. Irion
JDJ. Denton
J. Denton
MHM.C. Hillarby
M.C. Hillarby

1 August 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
IBIthar M. Beshtawi
Ithar M. Beshtawi
Riaz AkhtarRiaz Akhtar
Riaz Akhtar
MHM. Chantal Hillarby
M. Chantal Hillarby
COClare O'DOnnell
Clare O'DOnnell
XZXuegen Zhao
Xuegen Zhao
HRHema Radhakrishnan
Hema Radhakrishnan
Purpose. To assess and compare changes in the biomechanical properties of the cornea following different corneal collagen cross-linking protocols using scanning acoustic microscopy (SAM). Methods. Ten donor human corneal pairs were divided into two groups consisting of five corneal pairs in each group. In group A, five corneas were treated with low-fluence (370 nm, 3 mW/cm2) cross-linking (CXL) for 30 minutes. In group B, five corneas were treated with high-fluence (370 nm, 9 mW/cm2) CXL for 10 minutes. The contralateral control corneas in both groups had similar treatment but without ultraviolet A. The biomechanical properties of all corneas were tested using SAM. Results. In group A, the mean speed of sound in the treated corneas was 1677.38 ± 10.70 ms−1 anteriorly and 1603.90 ± 9.82 ms−1 posteriorly, while it was 1595.23 ± 9.66 ms−1 anteriorly and 1577.13 ± 8.16 ms−1 posteriorly in the control corneas. In group B, the mean speed of sound of the treated corneas was 1665.06 ± 9.54 ms−1 anteriorly and 1589.89 ± 9.73 ms−1 posteriorly, while it was 1583.55 ± 8.22 ms−1 anteriorly and 1565.46 ± 8.13 ms−1 posteriorly in the untreated control corneas. The increase in stiffness between the cross-linked and control corneas in both groups was by a factor of 1.051×. Conclusions. SAM successfully detected changes in the corneal stiffness after application of collagen cross-linking. A higher speed-of-sound value was found in the treated corneas when compared with the controls. No significant difference was found in corneal stiffness between the corneas cross-linked with low- and high-intensity protocols.

1 June 2000 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
HGHelen Green
Helen Green
ACAnn E. Canfield
Ann E. Canfield
MHM. Chantal Hillarby
M. Chantal Hillarby
MGMichael E. Grant
Michael E. Grant
RBRaymond P. Boot-Handford
Raymond P. Boot-Handford
GWGillian A. Dr. Wallis
Gillian A. Dr. Wallis
Endochondral ossification is a carefully coordinated developmental process that converts the cartilaginous model of the embryonic skeleton to bone with accompanying long bone growth. To identify genes that regulate this process we performed a complementary DNA (cDNA) subtractive hybridization of fetal bovine proliferative chondrocyte cDNA from epiphyseal cartilage cDNA. The subtracted product was used to screen a fetal bovine cartilage cDNA library. Ten percent of the clones identified encoded the bovine orthologue of the human ribosomal protein “QM.” Northern and western blot analysis confirmed that QM was highly expressed by cells isolated from epiphyseal cartilage as opposed to proliferative chondrocytes. In contrast, no detectable difference in the expression of mRNA for the ribosomal protein S11 was detected. Immunohistochemical analysis of fetal bovine limb sections revealed that QM was not expressed by the majority of the epiphyseal chondrocytes but only by chondrocytes in close proximity to capillaries that had invaded the epiphyseal cartilage. Strongest QM expression was seen in osteoblasts in the diaphyseal region of the bone adjoining the growth plate, within the periosteum covering the growth plate and within secondary centers of ossification. Hypertrophic chondrocytes within the growth plate adjoining the periosteum also were positive for QM as were chondrocytes in the perichondrium adjoining the periosteum. In vitro investigation of the expression of QM revealed higher QM expression in nonmineralizing osteoblast and pericyte cultures as compared with mineralizing cultures. The in vivo and in vitro expression pattern of QM suggests that this protein may have a role in cell differentiation before mineralization.

1 October 2016 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
EKEvgeny Kushnerev
Evgeny Kushnerev
SSSusan G. Shawcross
Susan G. Shawcross
SSShankari Sothirachagan
Shankari Sothirachagan
FCFiona Carley
Fiona Carley
ABArun Brahma
Arun Brahma
MHM. Chantal Hillarby
M. Chantal Hillarby
Purpose: The corneal epithelium is sloughed off surface of the eye by the action of blinking and is continually replaced by division and maturation of the limbal stem cells (LSCs). In the case of injury or disease, LSCs can be lost or damaged to a point at which the corneal epithelial layer is no longer maintained. leading to LSC deficiencies (LSCDs). When this occurs, the opaque conjunctiva overgrows the anterior surface of the eye, leading to vision impairment or loss. Dental pulp stem cells (DPSCs) are promising candidates as autologous LSC substitutes. In this study, contact lenses (CLs) are used as a novel medical device to deliver DPSCs onto corneal surface to enhance corneal epithelium regeneration. Methods: Dental pulp stem cells labeled with green fluorescent Qtracker 525 were seeded onto the pretreated CLs, allowed to adhere, then delivered to debrided human corneas. Expression of KRT3, 12, 13, and 19 was investigated by immunostaining, then standard and confocal microscopy. Results: Dental pulp stem cells were successfully isolated, labeled, and delivered to the corneal surface using CLs. Following removal of CLs, confocal microscopy showed that the DPSCs had migrated onto the cornea. Coexpression of KRT12 and green fluorescent Qtracker 525 confirmed that the DPSCs had transdifferentiated into corneal epithelial progenitors. Delimitation of KRT 19 and green fluorescence provides evidence that Qtracker 525-labeled DPSCs establish a barrier to the invasion of the cornea by conjunctiva. Conclusions: In this study we show that DPSCs, delivered using CLs, can be used to enhance repair and regeneration of the human corneal epithelium.